RSK3 switches cell fate: from stress-induced senescence to malignant progression.

Journal Information

Full Title: J Exp Clin Cancer Res

Abbreviation: J Exp Clin Cancer Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neoplasms

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"datasets are available in geo gse243320.; availability of data and materials transcriptomic datasets are available in geo gse243320.; the mass spectrometry proteomics data have been deposited to the proteomexchange consortium with the dataset identifier pxd045450 and 10 6019/pxd045450. availability of data and materials transcriptomic datasets are available in geo gse243320"

Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll animal experiments were conducted according to the European Communities Council Directive (2010/63/UE) for the care and use of animals for experimental procedures and complied with the regulations of the French Ethics Committee in Animal Experiment ‘Charles Darwin’ registered by the French authority under CE005. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no conflict of interest. Competing interests The authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding This work was carried out with the support of the French National Cancer Institute INCA (PLBio 15–013 to P.A.D. and D.B. and PLBio 18–144 to D.B.) and by committees from Ardèche and Saône-et-Loire de la Ligue contre le cancer. The proteomic experiments were partially supported by Agence Nationale de la Recherche under projects ProFI (Proteomics French Infrastructure, ANR-10-INBS-08) and GRAL, a program from the Chemistry Biology Health (CBH) Graduate School of University Grenoble Alpes (ANR-17-EURE-0003). A.H. was supported by the Fondation pour la recherche médicale FRM."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025